GlassScriptPhysician profile
Casey Lynn Gazda
NPI 1538548268
$2,358.64
in general payments reported to CMS, 2019-2025
12 companies · $32.81 in 2025
The $32.81 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.11 · 2020: $251 · 2021: $42.21 · 2022: $133 · 2023: $1,624 · 2024: $201 · 2025: $32.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,060 · Food and Beverage: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,060.35 |
| Food and Beverage | $797.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,565.62 | 2023-2025 | Pascal, Evoque |
| Pfizer INC. | $134.98 | 2020 | |
| Heartflow, INC. | $132.94 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $99.17 | 2020 | |
| Boston Scientific Corporation | $91.09 | 2023 | Watchman Access System |
| Novo Nordisk INC | $88.52 | 2024 | |
| Biosense Webster, INC. | $87.45 | 2024 | Nuvision Ice Catheter |
| Abbott Laboratories | $75.11 | 2019 | |
| Mallinckrodt Hospital Products INC. | $30.14 | 2021 | |
| Recor Medical INC | $24.69 | 2024 | Paradise Renal Denervation System |
| Irhythm Technologies, INC. | $16.86 | 2020 | |
| Medtronic, INC. | $12.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Gazda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.